Search





Search





Markets
/
Stocks
/
nasdaq-tech
/

Bio-Techne Corp

TECH

Add to Watchlist

44.900USD

-2.520-5.31%

Close 05/13, 16:00（ET）Quotes delayed by 15 min

7.03BMarket Cap

63.62P/E TTM



Bio-Techne Corp

44.900

-2.520-5.31%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

More Details of Bio-Techne Corp Company

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Bio-Techne Corp Info



Ticker SymbolTECH

Company nameBio-Techne Corp

IPO dateFeb 09, 1989

CEOKelderman (Kim)

Number of employees3100

Security typeOrdinary Share

Fiscal year-endFeb 09

Address614 Mckinley Pl N E

CityMINNEAPOLIS

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code55413

Phone16123798854

Websitehttps://www.bio-techne.com/

Ticker SymbolTECH

IPO dateFeb 09, 1989

CEOKelderman (Kim)

Company Executives of Bio-Techne Corp



Name

Name/Position

Position

Shareholding

Change

Mr. John L. Higgins

Independent Director

66.88K

+2.45%

Mr. Kim Kelderman

President, Chief Executive Officer, Director

63.06K

+22.83%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

46.50K

+3.53%

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

15.41K

+10.64%

Dr. Rupert J. Vessey, Ph.D.

Independent Director

10.99K

+14.93%

Ms. Julie L. Bushman

Independent Director

8.78K

+18.69%

Mr. Shane Bohnen

Senior Vice President, General Counsel, Corporate Secretary

5.90K

+25.73%

Dr. Judith V. Klimovsky, M.D.

Independent Director

3.78K

+43.36%

Mr. James T. (Jim) Hippel

Chief Financial Officer, Executive Vice President - Finance

Mr. David Clair

Investor Relations

Name

Name/Position

Position

Shareholding

Change

Mr. John L. Higgins

Independent Director

66.88K

+2.45%

Mr. Kim Kelderman

President, Chief Executive Officer, Director

63.06K

+22.83%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

46.50K

+3.53%

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

15.41K

+10.64%

Dr. Rupert J. Vessey, Ph.D.

Independent Director

10.99K

+14.93%

Ms. Julie L. Bushman

Independent Director

8.78K

+18.69%

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6

FY2026Q2

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Consumables

235.44M

79.57%

Instruments

29.61M

10.01%

Service

22.32M

7.54%

Royalty

8.51M

2.88%

By RegionUSD

Name

Revenue

Proportion

United States

146.56M

49.53%

EMEA, excluding U.K

75.35M

25.47%

Greater China

26.35M

8.91%

APAC, excluding Greater China

22.74M

7.69%

United Kingdom

13.73M

4.64%

Rest of World

11.14M

3.77%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Consumables

235.44M

79.57%

Instruments

29.61M

10.01%

Service

22.32M

7.54%

Royalty

8.51M

2.88%

Shareholding Stats

Updated: Mon, May 11

Shareholders

Shareholder Types

Shareholders

Proportion

Vanguard Capital Management, LLC

6.50%

BlackRock Institutional Trust Company, N.A.

5.84%

Vanguard Portfolio Management, LLC

4.14%

State Street Investment Management (US)

3.71%

Wellington Management Company, LLP

3.66%

Other

76.15%

Shareholders

Proportion

Vanguard Capital Management, LLC

6.50%

BlackRock Institutional Trust Company, N.A.

5.84%

Vanguard Portfolio Management, LLC

4.14%

State Street Investment Management (US)

3.71%

Wellington Management Company, LLP

3.66%

Other

76.15%

Shareholder Types

Shareholders

Proportion

Investment Advisor

60.05%

Investment Advisor/Hedge Fund

37.12%

Hedge Fund

9.13%

Research Firm

2.58%

Bank and Trust

1.97%

Pension Fund

1.77%

Sovereign Wealth Fund

1.08%

Individual Investor

0.30%

Insurance Company

0.23%

Institutional Shareholding



Updated: Sun, Apr 5

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q1

1247

178.19M

113.81%

+1.43K

2025Q4

1230

172.60M

110.32%

+3.07M

2025Q3

1198

161.18M

103.53%

-7.34M

2025Q2

1209

165.25M

105.41%

-730.33K

2025Q1

1245

168.10M

107.22%

+1.54M

2024Q4

1233

162.21M

102.61%

-6.39M

2024Q3

1205

159.40M

100.49%

-10.21M

2024Q2

1207

160.52M

101.86%

-12.24M

2024Q1

1216

162.56M

103.40%

-7.57M

2023Q4

1229

159.70M

100.98%

-3.97M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

BlackRock Institutional Trust Company, N.A.

9.14M

5.84%

+350.80K

+3.99%

Dec 31, 2025

State Street Investment Management (US)

5.81M

3.71%

+58.64K

+1.02%

Dec 31, 2025

Wellington Management Company, LLP

5.73M

3.67%

+618.92K

+12.10%

Dec 31, 2025

Geode Capital Management, L.L.C.

4.93M

3.15%

+2.62K

+0.05%

Dec 31, 2025

Atlanta Capital Management Company, L.L.C.

4.83M

3.08%

-115.50K

-2.34%

Dec 31, 2025

MFS Investment Management

3.91M

2.5%

+2.46M

+169.79%

Dec 31, 2025

Maverick Capital, Ltd.

3.85M

2.46%

+838.27K

+27.82%

Dec 31, 2025

T. Rowe Price Associates, Inc.

3.85M

2.46%

+725.05K

+23.23%

Dec 31, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

Global X Genomics & Biotechnology ETF

4.29%

Invesco Biotechnology & Genome ETF

2.92%

Invesco S&P 500 Equal Weight Health Care ETF

Neuberger Berman Small-Mid Cap ETF

1.78%

VanEck Biotech ETF

1.73%

Hilton Small-MidCap Opportunity ETF

1.7%

iShares Health Innovation Active ETF

1.68%

American Century Mid Cap Growth Impact ETF

1.47%

Thrivent Small-Mid Cap ESG ETF

1.34%

Invesco S&P 500 High Beta ETF

1.06%

Global X Genomics & Biotechnology ETF

Proportion4.29%

Invesco Biotechnology & Genome ETF

Proportion2.92%

Invesco S&P 500 Equal Weight Health Care ETF

Proportion2%

Neuberger Berman Small-Mid Cap ETF

Proportion1.78%

VanEck Biotech ETF

Proportion1.73%

Hilton Small-MidCap Opportunity ETF

Proportion1.7%

iShares Health Innovation Active ETF

Proportion1.68%

American Century Mid Cap Growth Impact ETF

Proportion1.47%

Thrivent Small-Mid Cap ESG ETF

Proportion1.34%

Invesco S&P 500 High Beta ETF

Proportion1.06%

Dividend



A total of 250.90M USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

May 06, 2026

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 29, 2026 going ex on May 18, 2026

May 18, 2026

May 29, 2026

May 18, 2026

Feb 04, 2026

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 27, 2026 going ex on Feb 13, 2026

Feb 16, 2026

Feb 27, 2026

Feb 13, 2026

Nov 05, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 28, 2025 going ex on Nov 17, 2025

Nov 17, 2025

Nov 28, 2025

Nov 17, 2025

Aug 06, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 29, 2025 going ex on Aug 18, 2025

Aug 18, 2025

Aug 29, 2025

Aug 18, 2025

May 07, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 30, 2025 going ex on May 19, 2025

May 19, 2025

May 30, 2025

May 19, 2025

Feb 05, 2025

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025

Feb 17, 2025

Feb 28, 2025

Feb 14, 2025

Oct 30, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024

Nov 11, 2024

Nov 22, 2024

Nov 08, 2024

Aug 07, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024

Aug 19, 2024

Aug 30, 2024

Aug 19, 2024

May 01, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024

May 13, 2024

May 24, 2024

May 10, 2024

Feb 01, 2024

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024

Feb 12, 2024

Feb 26, 2024

Feb 09, 2024

Stock Splits



Date

Ex-dividend Date

Type

Ratio

Nov 01, 2022

Split

1→4

Date

Ex-dividend Date

Type

Ratio

Nov 01, 2022

Split

1→4

KeyAI

